We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
(-1.3%)
Cap. Flow
-$2.05B
Cap. Flow
% of AUM
-8.13%
Top 10 Holdings %
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$160M |
| 2 |
Masco
MAS
|
+$134M |
| 3 |
Lam Research
LRCX
|
+$112M |
| 4 |
Coupang
CPNG
|
+$101M |
| 5 |
Nu Holdings
NU
|
+$98.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GE Vernova
GEV
|
+$205M |
| 2 |
Lennox International
LII
|
+$191M |
| 3 |
NVIDIA
NVDA
|
+$169M |
| 4 |
Tractor Supply
TSCO
|
+$157M |
| 5 |
Apple
AAPL
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.69% |
| 2 | Consumer Discretionary | 12.85% |
| 3 | Industrials | 12.71% |
| 4 | Financials | 12.68% |
| 5 | Healthcare | 9.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
NVIDIA
NVDA
$5.08T
| $1.67B | 6.63% |
8,939,370
-968,754
| -10% | -$169M |
|
|
2
Apple
AAPL
$4.71T
| $1.33B | 5.29% |
5,228,272
-666,379
| -11% | -$151M |
|
3
Microsoft
MSFT
$2.83T
| $1.02B | 4.05% |
1,968,436
-122,668
| -6% | -$62.6M |
|
4
Meta Platforms (Facebook)
META
$1.54T
| $484M | 1.92% |
658,563
-69,523
| -10% | -$51.7M |
|
5
Alphabet (Google) Class C
GOOG
$3.91T
| $471M | 1.87% |
1,934,783
-438,322
| -18% | -$92.1M |
|
6
Arista Networks
ANET
$223B
| $380M | 1.51% |
2,605,067
-727,907
| -22% | -$93.7M |
|
7
Booking.com
BKNG
$134B
| $370M | 1.47% |
1,713,825
-129,775
| -7% | -$29M |
|
8
Qualcomm
QCOM
$179B
| $369M | 1.47% |
2,216,925
-120,048
| -5% | -$19M |
|
9
O'Reilly Automotive
ORLY
$71B
| $340M | 1.35% |
3,154,278
-252,829
| -7% | -$25.4M |
|
10
Amazon
AMZN
$2.52T
| $332M | 1.32% |
1,513,246
-402,182
| -21% | -$91M |
|
11
McKesson
MCK
$95.6B
| $329M | 1.31% |
425,299
-24,257
| -5% | -$17.1M |
|
12
Interactive Brokers
IBKR
$40.8B
| $326M | 1.3% |
4,737,541
-659,389
| -12% | -$41.5M |
|
13
Adobe
ADBE
$84.5B
| $311M | 1.24% |
881,804
+53,151
| +6% | +$19.1M |
|
14
General Motors
GM
$72.4B
| $254M | 1.01% |
4,160,159
+75,339
| +2% | +$4.2M |
|
15
Edwards Lifesciences
EW
$48.1B
| $239M | 0.95% |
3,078,289
-362,226
| -11% | -$28.3M |
|
|
16
Lam Research
LRCX
$401B
| $238M | 0.95% |
1,779,716
+1,056,502
| +146% | +$112M |
|
17
VeriSign
VRSN
$23.3B
| $233M | 0.93% |
833,961
-82,126
| -9% | -$22.9M |
|
18
Comfort Systems
FIX
$65.2B
| $225M | 0.89% |
272,441
-28,113
| -9% | -$19.1M |
|
19
Jabil
JBL
$33.8B
| $223M | 0.89% |
1,027,932
-80,296
| -7% | -$17.5M |
|
20
Target
TGT
$61.1B
| $210M | 0.84% |
2,344,046
+231,825
| +11% | +$22.8M |
|
21
Emcor
EME
$34B
| $207M | 0.82% |
318,174
+5,438
| +2% | +$3.3M |
|
22
Monster Beverage
MNST
$91.4B
| $206M | 0.82% |
3,059,915
-4,752
| -0.2% | -$297K |
|
23
Phillips 66
PSX
$84.1B
| $193M | 0.77% |
1,422,236
-99,058
| -7% | -$12.7M |
|
|
24
Alnylam Pharmaceuticals
ALNY
$35.8B
| $187M | 0.74% |
410,342
+392,668
| +2,222% | +$160M |
|
25
Broadcom
AVGO
$1.86T
| $178M | 0.71% |
539,483
+154,810
| +40% | +$47.5M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2025 Portfolio in Review
As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.
Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.
- Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
- Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
- Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
- Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
- Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
- Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.